AFCM
TMO icon

Applied Finance Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Applied Finance Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.52M Sell
18,993
-4,363
-19% -$2.09M 0.71% 52
2026
Q1 		$11.5M Sell
23,356
-1,027
-4% -$557K 0.86% 48
2025
Q4 		$14.1M Sell
24,383
-5,104
-17% -$2.89M 1.01% 43
2025
Q3 		$14.3M Sell
29,487
-1,441
-5% -$671K 1.02% 39
2025
Q2 		$12.5M Buy
30,928
+2,708
+10% +$1.13M 0.86% 46
2025
Q1 		$14M Sell
28,220
-22,549
-44% -$12.2M 1.03% 40
2024
Q4 		$26.4M Sell
50,769
-1,744
-3% -$959K 1.15% 40
2024
Q3 		$32.5M Buy
52,513
+665
+1% +$394K 1.39% 31
2024
Q2 		$28.7M Buy
51,848
+16,165
+45% +$9.26M 1.33% 38
2024
Q1 		$20.7M Buy
35,683
+4,117
+13% +$2.31M 1.46% 41
2023
Q4 		$16.8M Buy
31,566
+3,297
+12% +$1.6M 1.46% 40
2023
Q3 		$14.3M Buy
28,269
+2,196
+8% +$1.17M 1.56% 39
2023
Q2 		$13.6M Buy
26,073
+887
+4% +$479K 1.54% 37
2023
Q1 		$14.5M Buy
25,186
+304
+1% +$171K 1.81% 27
2022
Q4 		$13.7M Buy
+24,882
New +$13.2M 1.79% 28

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Applied Finance Capital Management's TMO Position: Q2 2026 in Review

Applied Finance Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, selling an estimated $2.09M and leaving 18,993 shares worth $9.52M. The position accounts for 0.71% of the portfolio, ranked #52.

Applied Finance Capital Management first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $32.5M in Q3 2024. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Applied Finance Capital Management held 18,993 shares of Thermo Fisher Scientific worth $9.52M as of Q2 2026.
  • Applied Finance Capital Management sold 4,363 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.09M.
  • Thermo Fisher Scientific made up 0.71% of Applied Finance Capital Management's portfolio in Q2 2026, its #52 holding.
  • Applied Finance Capital Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Applied Finance Capital Management's Thermo Fisher Scientific position peaked at $32.5M in Q3 2024.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.